Bixiye
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Taariikhda barnaamijka Dhaqangalayso Agosto 21, 2018
Natiijooyinka Raadinta
Soo bandhiga 2951 - 2960 ee natiijooyinka 3688
Bixiye
QP28-17 Notification of Provider Submitted Appeals
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 12, 2017
Bixiye
QP82-18 Pharmacy Benefit Exclusion for Azedra (iobenguane I 131) Intravenous Injection
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 28, 2018
Bixiye
QP86-18 Addition of Drug to the Calcitonin Gene-Related Peptide (CGRP) Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2018
Bixiye
QP35-17 Implementation of New Utilization Management Platform
Taariikhda uu dhaqangalayo Barnaamijka: Nov 07, 2017
Bixiye
QP85-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Pseudobulbar Affect (PBA)
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2018
Bixiye
QP37-17 APR-DRG and EAPG Grouper Updates
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2017
Bixiye
QP4-16 Pre-Admission Notification Submissions on the Availity Web Portal
Taariikhda uu dhaqangalayo Barnaamijka: 05, Feb 2016
Bixiye
QP98-18 Migration of Minnesota Health Care Programs Subscribers to Amerigroup Delayed to January 1, 2109
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2018
Bixiye
QP95-18 Provider Cost Data Update
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2018